Serveur d'exploration Tocilizumab

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

IL6 receptor blockade preserves articular cartilage and increases bone volume following ischemic osteonecrosis in immature mice.

Identifieur interne : 000C20 ( Main/Exploration ); précédent : 000C19; suivant : 000C21

IL6 receptor blockade preserves articular cartilage and increases bone volume following ischemic osteonecrosis in immature mice.

Auteurs : N. Kamiya [Japon] ; G. Kuroyanagi [États-Unis] ; O. Aruwajoye [États-Unis] ; H K W. Kim [États-Unis]

Source :

RBID : pubmed:30404032

Descripteurs français

English descriptors

Abstract

Juvenile ischemic osteonecrosis (JIO) of the femoral head is one of the most serious hip disorders causing a permanent deformity of the femoral head in childhood. We recently reported that interleukin 6 (IL6) is predominantly increased in the hip synovial fluid of patients with JIO and that articular chondrocytes are primary source of IL6. This study investigated whether an inhibition of IL6 receptor improves cartilage preservation and bone healing in JIO.

DOI: 10.1016/j.joca.2018.10.010
PubMed: 30404032


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">IL6 receptor blockade preserves articular cartilage and increases bone volume following ischemic osteonecrosis in immature mice.</title>
<author>
<name sortKey="Kamiya, N" sort="Kamiya, N" uniqKey="Kamiya N" first="N" last="Kamiya">N. Kamiya</name>
<affiliation wicri:level="1">
<nlm:affiliation>Center for Excellence in Hip Disorders, Texas Scottish Rite Hospital for Children, Dallas, TX 75219, USA; Orthopaedic Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390-8883, USA; Sports Medicine, Tenri University, Tenri 632-8510, Japan. Electronic address: nkamiya1@sta.tenri-u.ac.jp.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Center for Excellence in Hip Disorders, Texas Scottish Rite Hospital for Children, Dallas, TX 75219, USA; Orthopaedic Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390-8883, USA; Sports Medicine, Tenri University, Tenri 632-8510</wicri:regionArea>
<wicri:noRegion>Tenri 632-8510</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kuroyanagi, G" sort="Kuroyanagi, G" uniqKey="Kuroyanagi G" first="G" last="Kuroyanagi">G. Kuroyanagi</name>
<affiliation wicri:level="2">
<nlm:affiliation>Center for Excellence in Hip Disorders, Texas Scottish Rite Hospital for Children, Dallas, TX 75219, USA. Electronic address: kokuryugen@yahoo.co.jp.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Excellence in Hip Disorders, Texas Scottish Rite Hospital for Children, Dallas, TX 75219</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Aruwajoye, O" sort="Aruwajoye, O" uniqKey="Aruwajoye O" first="O" last="Aruwajoye">O. Aruwajoye</name>
<affiliation wicri:level="2">
<nlm:affiliation>Center for Excellence in Hip Disorders, Texas Scottish Rite Hospital for Children, Dallas, TX 75219, USA. Electronic address: ooaruwajoye@gmail.com.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Excellence in Hip Disorders, Texas Scottish Rite Hospital for Children, Dallas, TX 75219</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kim, H K W" sort="Kim, H K W" uniqKey="Kim H" first="H K W" last="Kim">H K W. Kim</name>
<affiliation wicri:level="2">
<nlm:affiliation>Center for Excellence in Hip Disorders, Texas Scottish Rite Hospital for Children, Dallas, TX 75219, USA; Orthopaedic Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390-8883, USA. Electronic address: Harry.Kim@tsrh.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Excellence in Hip Disorders, Texas Scottish Rite Hospital for Children, Dallas, TX 75219, USA; Orthopaedic Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390-8883</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:30404032</idno>
<idno type="pmid">30404032</idno>
<idno type="doi">10.1016/j.joca.2018.10.010</idno>
<idno type="wicri:Area/PubMed/Corpus">000613</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000613</idno>
<idno type="wicri:Area/PubMed/Curation">000613</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000613</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000453</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000453</idno>
<idno type="wicri:Area/Ncbi/Merge">001C69</idno>
<idno type="wicri:Area/Ncbi/Curation">001C69</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001C69</idno>
<idno type="wicri:Area/Main/Merge">000C20</idno>
<idno type="wicri:Area/Main/Curation">000C20</idno>
<idno type="wicri:Area/Main/Exploration">000C20</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">IL6 receptor blockade preserves articular cartilage and increases bone volume following ischemic osteonecrosis in immature mice.</title>
<author>
<name sortKey="Kamiya, N" sort="Kamiya, N" uniqKey="Kamiya N" first="N" last="Kamiya">N. Kamiya</name>
<affiliation wicri:level="1">
<nlm:affiliation>Center for Excellence in Hip Disorders, Texas Scottish Rite Hospital for Children, Dallas, TX 75219, USA; Orthopaedic Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390-8883, USA; Sports Medicine, Tenri University, Tenri 632-8510, Japan. Electronic address: nkamiya1@sta.tenri-u.ac.jp.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Center for Excellence in Hip Disorders, Texas Scottish Rite Hospital for Children, Dallas, TX 75219, USA; Orthopaedic Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390-8883, USA; Sports Medicine, Tenri University, Tenri 632-8510</wicri:regionArea>
<wicri:noRegion>Tenri 632-8510</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kuroyanagi, G" sort="Kuroyanagi, G" uniqKey="Kuroyanagi G" first="G" last="Kuroyanagi">G. Kuroyanagi</name>
<affiliation wicri:level="2">
<nlm:affiliation>Center for Excellence in Hip Disorders, Texas Scottish Rite Hospital for Children, Dallas, TX 75219, USA. Electronic address: kokuryugen@yahoo.co.jp.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Excellence in Hip Disorders, Texas Scottish Rite Hospital for Children, Dallas, TX 75219</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Aruwajoye, O" sort="Aruwajoye, O" uniqKey="Aruwajoye O" first="O" last="Aruwajoye">O. Aruwajoye</name>
<affiliation wicri:level="2">
<nlm:affiliation>Center for Excellence in Hip Disorders, Texas Scottish Rite Hospital for Children, Dallas, TX 75219, USA. Electronic address: ooaruwajoye@gmail.com.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Excellence in Hip Disorders, Texas Scottish Rite Hospital for Children, Dallas, TX 75219</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kim, H K W" sort="Kim, H K W" uniqKey="Kim H" first="H K W" last="Kim">H K W. Kim</name>
<affiliation wicri:level="2">
<nlm:affiliation>Center for Excellence in Hip Disorders, Texas Scottish Rite Hospital for Children, Dallas, TX 75219, USA; Orthopaedic Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390-8883, USA. Electronic address: Harry.Kim@tsrh.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Excellence in Hip Disorders, Texas Scottish Rite Hospital for Children, Dallas, TX 75219, USA; Orthopaedic Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390-8883</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Osteoarthritis and cartilage</title>
<idno type="eISSN">1522-9653</idno>
<imprint>
<date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Antibodies, Monoclonal, Humanized (pharmacology)</term>
<term>Antibodies, Monoclonal, Humanized (therapeutic use)</term>
<term>Bone Remodeling (drug effects)</term>
<term>Cartilage, Articular (drug effects)</term>
<term>Cartilage, Articular (metabolism)</term>
<term>Cartilage, Articular (pathology)</term>
<term>Cells, Cultured</term>
<term>Chondrocytes (drug effects)</term>
<term>Chondrocytes (pathology)</term>
<term>Disease Models, Animal</term>
<term>Drug Evaluation, Preclinical (methods)</term>
<term>Femur (metabolism)</term>
<term>Femur (pathology)</term>
<term>Interleukin-6 (metabolism)</term>
<term>Metabolism (drug effects)</term>
<term>Mice, Inbred C57BL</term>
<term>Molecular Targeted Therapy (methods)</term>
<term>Osteonecrosis (drug therapy)</term>
<term>Osteonecrosis (pathology)</term>
<term>Receptors, Interleukin-6 (antagonists & inhibitors)</term>
<term>Receptors, Interleukin-6 (physiology)</term>
<term>SOX9 Transcription Factor (genetics)</term>
<term>SOX9 Transcription Factor (metabolism)</term>
<term>Up-Regulation (drug effects)</term>
<term>X-Ray Microtomography</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Anticorps monoclonaux humanisés (pharmacologie)</term>
<term>Anticorps monoclonaux humanisés (usage thérapeutique)</term>
<term>Cartilage articulaire ()</term>
<term>Cartilage articulaire (anatomopathologie)</term>
<term>Cartilage articulaire (métabolisme)</term>
<term>Cellules cultivées</term>
<term>Chondrocytes ()</term>
<term>Chondrocytes (anatomopathologie)</term>
<term>Facteur de transcription SOX-9 (génétique)</term>
<term>Facteur de transcription SOX-9 (métabolisme)</term>
<term>Fémur (anatomopathologie)</term>
<term>Fémur (métabolisme)</term>
<term>Interleukine-6 (métabolisme)</term>
<term>Microtomographie aux rayons X</term>
<term>Modèles animaux de maladie humaine</term>
<term>Métabolisme ()</term>
<term>Ostéonécrose (anatomopathologie)</term>
<term>Ostéonécrose (traitement médicamenteux)</term>
<term>Remodelage osseux ()</term>
<term>Récepteurs à l'interleukine-6 (antagonistes et inhibiteurs)</term>
<term>Récepteurs à l'interleukine-6 (physiologie)</term>
<term>Régulation positive ()</term>
<term>Souris de lignée C57BL</term>
<term>Thérapie moléculaire ciblée ()</term>
<term>Évaluation préclinique de médicament ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>Receptors, Interleukin-6</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>SOX9 Transcription Factor</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Interleukin-6</term>
<term>SOX9 Transcription Factor</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Antibodies, Monoclonal, Humanized</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en">
<term>Receptors, Interleukin-6</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antibodies, Monoclonal, Humanized</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Cartilage articulaire</term>
<term>Chondrocytes</term>
<term>Fémur</term>
<term>Ostéonécrose</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr">
<term>Récepteurs à l'interleukine-6</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Bone Remodeling</term>
<term>Cartilage, Articular</term>
<term>Chondrocytes</term>
<term>Metabolism</term>
<term>Up-Regulation</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Osteonecrosis</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Facteur de transcription SOX-9</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Cartilage, Articular</term>
<term>Femur</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Drug Evaluation, Preclinical</term>
<term>Molecular Targeted Therapy</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Cartilage articulaire</term>
<term>Facteur de transcription SOX-9</term>
<term>Fémur</term>
<term>Interleukine-6</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Cartilage, Articular</term>
<term>Chondrocytes</term>
<term>Femur</term>
<term>Osteonecrosis</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Anticorps monoclonaux humanisés</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Récepteurs à l'interleukine-6</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Ostéonécrose</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Anticorps monoclonaux humanisés</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Cells, Cultured</term>
<term>Disease Models, Animal</term>
<term>Mice, Inbred C57BL</term>
<term>X-Ray Microtomography</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Cartilage articulaire</term>
<term>Cellules cultivées</term>
<term>Chondrocytes</term>
<term>Microtomographie aux rayons X</term>
<term>Modèles animaux de maladie humaine</term>
<term>Métabolisme</term>
<term>Remodelage osseux</term>
<term>Régulation positive</term>
<term>Souris de lignée C57BL</term>
<term>Thérapie moléculaire ciblée</term>
<term>Évaluation préclinique de médicament</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Juvenile ischemic osteonecrosis (JIO) of the femoral head is one of the most serious hip disorders causing a permanent deformity of the femoral head in childhood. We recently reported that interleukin 6 (IL6) is predominantly increased in the hip synovial fluid of patients with JIO and that articular chondrocytes are primary source of IL6. This study investigated whether an inhibition of IL6 receptor improves cartilage preservation and bone healing in JIO.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Japon</li>
<li>États-Unis</li>
</country>
<region>
<li>Texas</li>
</region>
</list>
<tree>
<country name="Japon">
<noRegion>
<name sortKey="Kamiya, N" sort="Kamiya, N" uniqKey="Kamiya N" first="N" last="Kamiya">N. Kamiya</name>
</noRegion>
</country>
<country name="États-Unis">
<region name="Texas">
<name sortKey="Kuroyanagi, G" sort="Kuroyanagi, G" uniqKey="Kuroyanagi G" first="G" last="Kuroyanagi">G. Kuroyanagi</name>
</region>
<name sortKey="Aruwajoye, O" sort="Aruwajoye, O" uniqKey="Aruwajoye O" first="O" last="Aruwajoye">O. Aruwajoye</name>
<name sortKey="Kim, H K W" sort="Kim, H K W" uniqKey="Kim H" first="H K W" last="Kim">H K W. Kim</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C20 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000C20 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:30404032
   |texte=   IL6 receptor blockade preserves articular cartilage and increases bone volume following ischemic osteonecrosis in immature mice.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:30404032" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a TocilizumabV1 

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021